Patents by Inventor Xue Ge

Xue Ge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ORAL TABLET FORMULATIONS
    Publication number: 20210085672
    Abstract: Described herein are solid, pharmaceutical compositions, dosage forms and methods of making and using the same, wherein the solid compositions comprise at least one high viscosity agent. The solid, high viscosity agent-comprising pharmaceutical compositions, when comprised of an opioid drug, can reduce the potential for abuse of such drug. The solid dosage forms are characterized by having a significantly reduced extractability of an opioid drug comprised therein upon contact of the dosage form with a solvent such as a typical household solvent. The solid dosage forms, following contact with a household solvent, such as an aqueous or alcoholic solvent, generate a high viscosity solution, thereby discouraging abuse of the resulting formulation via intravenous (IV) injection.
    Type: Application
    Filed: July 25, 2018
    Publication date: March 25, 2021
    Inventors: Sindhuri Maddineni, Shailendra Mandge, Sourish Mukherjee, Vinod Balakrishnan Nair, Vijaya Srinivas Sekuboyina, Praveen Gaddam, Kevin J. Brodbeck, Ramakrishna Gadiraju, Xue Ge, Michael A. Eldon, Aleksandrs Odinecs, Satyanarayana Goda, Rajendra Tandale, Shiladitya Bhattacharya
  • Tazarotene derivatives
    Patent number: 9062037
    Abstract: The presently described subject matter relates to new derivatives of tazarotene that also exhibit retinoid activity, pharmaceutical compositions comprising the derivatives, method of treating skin disorders with the pharmaceutical compositions, and process of making the derivatives.
    Type: Grant
    Filed: August 20, 2014
    Date of Patent: June 23, 2015
    Assignee: Stiefel Laboratories, Inc.
    Inventors: Xue Ge, Hansen Wong, Wendy Huang Chern, Hans Hofland, Michael J. Bishop, Xin Frank Cai, Alan Colborn
  • TAZAROTENE DERIVATIVES
    Publication number: 20140357669
    Abstract: The presently described subject matter relates to new derivatives of tazarotene that also exhibit retinoid activity, pharmaceutical compositions comprising the derivatives, method of treating skin disorders with the pharmaceutical compositions, and process of making the derivatives.
    Type: Application
    Filed: August 20, 2014
    Publication date: December 4, 2014
    Inventors: Xue GE, Hansen WONG, Wendy Huang CHERN, Hans HOFLAND, Michael J. BISHOP, Xin Frank CAI, Alan COLBORN
  • TAZAROTENE DERIVATIVES
    Publication number: 20140357672
    Abstract: The presently described subject matter relates to new derivatives of tazarotene that also exhibit retinoid activity, pharmaceutical compositions comprising the derivatives, method of treating skin disorders with the pharmaceutical compositions, and process of making the derivatives.
    Type: Application
    Filed: August 20, 2014
    Publication date: December 4, 2014
    Inventors: Xue GE, Hansen WONG, Wendy Huang CHERN, Hans HOFLAND, Michael J. BISHOP, Xin Frank CAI, Alan COLBORN
  • TAZAROTENE DERIVATIVES
    Publication number: 20120115909
    Abstract: The presently described subject matter relates to new derivatives of tazarotene that also exhibit retinoid activity, pharmaceutical compositions comprising the derivatives, method of treating skin disorders with the pharmaceutical compositions, and process of making the derivatives.
    Type: Application
    Filed: July 16, 2010
    Publication date: May 10, 2012
    Inventors: Xue Ge, Hansen Wong, Wendy Huang Chern, Hans Hofland, Michael J. Bishop, Xin Frank Cai, Alan Colborn